Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel ultrasonic-microwave method for Palbociclib reduces cost and improves purity. Reliable supply chain partner for CDK4/6 inhibitor intermediates.
Patent CN101285085A reveals a high-efficiency whole cell catalysis method for Adenosylmethionine, offering superior conversion rates and simplified purification for global supply chains.
Patent CN106086126A reveals immobilized enzyme method for glutathione. Offers high purity, ATP regeneration, and cost reduction for pharmaceutical intermediates manufacturing.
Novel photochemical synthesis method ensures high purity and yield for Nicergoline intermediates, offering significant supply chain stability and cost optimization for global pharmaceutical manufacturers.
Novel patent CN103992212A details high-purity cis-benvitimod synthesis. Offers supply chain stability and cost reduction for pharmaceutical intermediates manufacturing globally.
Patent CN109665999B details a novel U-type template strategy for meta-selective C-H activation, offering cost reduction in API manufacturing and scalable routes for high-purity intermediates.
Novel patent CN103980263A offers high-yield Canagliflozin route. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Advanced stereoselective synthesis of Phencyclonate optical isomers via Mandelic acid template. Superior purity and scalable route for pharmaceutical manufacturing.
Patent CN104311532B details a robust synthesis for Canagliflozin intermediates. Discover cost-effective, scalable manufacturing solutions for pharmaceutical supply chains.
Patent CN118084664A reveals continuous synthesis for ethyl 6 8-dichlorooctanoate. Enhances purity and supply chain reliability for lipoic acid production globally.
Novel preparation method reduces cost and improves yield for Vortioxetine manufacturing ensuring supply chain stability and high purity standards for global pharmaceutical partners
Patent CN113528472B details a novel P450 BM3 mutant route for Trenbolone Acetate. Discover cost reduction in steroid manufacturing and high-purity intermediate supply strategies.
Patent CN105779522B details high-yield enzymatic synthesis. Offers scalable production and purity for pharmaceutical supply chains.
Novel 2-step synthesis of ethyl 24-cholenoate with high yield. Ideal for reliable pharmaceutical intermediate supplier seeking cost-effective Vitamin D3 metabolite precursors.
Efficient 6-step route to (+)-γ-lycorane from lactone. High purity, scalable process for pharma intermediates reducing cost and lead time.
Patent CN101142211B details a robust resolution process for cis-oxathiolane cytosine derivatives, offering significant cost reduction and supply chain reliability for antiviral API manufacturing.
Patent CN107778349A details a low-cost GHK acetate synthesis. Trt protection ensures purity and eliminates TFA, offering supply chain advantages.
Discover a scalable stereoselective process for chiral 2-[(hetero)aralkylthio]pyrimidines. Achieve high chiral purity without chiral HPLC for cost-effective API manufacturing.
Novel Lesinurad synthesis patent CN106866560A offers high yield and purity. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Novel preparation method for Dolutegravir Impurity A and B via CN110655517A. Offers high-purity reference standards and scalable routes for HIV drug quality control.